home / stock / qtnt / qtnt news


QTNT News and Press, Quotient Limited From 01/26/22

Stock Information

Company Name: Quotient Limited
Stock Symbol: QTNT
Market: NASDAQ

Menu

QTNT QTNT Quote QTNT Short QTNT News QTNT Articles QTNT Message Board
Get QTNT Alerts

News, Short Squeeze, Breakout and More Instantly...

QTNT - Quotient Limited Launches Scientific Advisory Board and Research Programs

MosaiQ virtual Scientific Advisory Board (SAB) was attended this week by eight Key Opinion Leaders (KOLs) from the US and various European countries Quotient’s focus is to strengthen MosaiQ scientific and medical evidence through the Innovator’s Circle and Investigator...

QTNT - Swiss diagnostics company Quotient Limited up 20% on 2x higher than normal volume

Swiss diagnostics company Quotient Limited (QTNT +20.6%) is up significantly today on volume nearly 2x higher than the daily average. Average shares trading hands is 857,241. As of 357p, the figure was 1,615,008. Quotient's business is focused on transfusion diagnostics. It has two product: M...

QTNT - Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress

Received feedback from the European notified body after review of Expanded IH submission Pleased with feedback and expect to submit a response to the questions in the next couple of weeks Continue to expect approval in Q1 CY 2022 JERSEY, Channel Islands, Dec. 15, 2021 (GLO...

QTNT - FREQ, CRTO and GDEV among after hour movers

Gainers: Stitch Fix  (NASDAQ:SFIX) +2%. Fate Therapeutics (NASDAQ:FATE) +2%. Frequency Therapeutics (NASDAQ:FREQ) +1%. Criteo  (NASDAQ:CRTO) +1%. EVgo  (NASDAQ:EVGO) +1%. Losers: Nexters  (NASDAQ:GDEV) -3%. Ocular Therapeutix (NASDAQ:OCUL) -2%. Sig...

QTNT - Quotient Limited Announces Appointment of Chief Manufacturing Operations Officer

JERSEY, Channel Islands, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Mr. Esteban Uriarte as the Company’s Chief Manufacturing Operations Officer (CMOO). Mr. Uriarte will assume the responsibilities of CMOO...

QTNT - Quotient EPS misses by $0.02, beats on revenue

Quotient (NASDAQ:QTNT): Q2 GAAP EPS of -$0.28 misses by $0.02. Revenue of $9.47M (-41.1% Y/Y) beats by $0.73M. Press Release For further details see: Quotient EPS misses by $0.02, beats on revenue

QTNT - Quotient Limited Provides Second Quarter Fiscal 2022 Results

Alba by Quotient: Revenues exceeded guidance; Achieved year-over year growth in Q2 FY 2022 of 15.9% Financial Position: Available cash & short-term investments of $141.8 million Business Update: Communication issued on November 9, 2021; providing a progress update ...

QTNT - Quotient Limited to Participate in the Jefferies London Healthcare Conference

JERSEY, Channel Islands, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the management team will present at the Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 8:40am GMT (3:40am...

QTNT - Quotient Limited (QTNT) CEO Manuel Méndez on Q2 2022 Results - Earnings Call Transcript

Quotient Limited (QTNT) Q2 2022 Results Earnings Conference Call November 9, 2021, 08:00 AM ET Company Participants Peter Buhler - Financial Advisor Manuel Méndez - Chief Executive Officer Ali Kiboro - Chief Financial Officer Conference Call Participants Joshua Jennings - Cowen and Compa...

QTNT - Quotient Limited Provides Business Update and Delays Releasing Second Quarter Fiscal 2022 Results

Executive Leadership Team: Recent new hires will support anticipated rapid growth and help lead future development MosaiQ™ Solution Transfusion Dx: The Expanded Immunohematology CE regulatory dossier has been submitted with 20 specificities; and Expanded Serolog...

Previous 10 Next 10